CLINICAL_TRIALS
trial_result
· 2017-12-12
Clinical Trial Update: Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea [Phase 4]
Summary
A Phase 4 study validating stimulated ∆FGF19 as a diagnostic biomarker for bile acid malabsorption (bile acid diarrhoea) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lars Kristian Munck | Conditions: Bile Acid Malabsorption | Phase 4 | Status: COMPLETED